At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 19 enrolled
Drug / intervention
Budesonide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Investigate the Potential of Buparid/PARI SINUS Versus Budes® Nasal Spray to Avoid or Postpone Sinus Surgery in Adult Patients With Chronic Rhinosinusitis
In Brief
A Phase 2 clinical trial evaluating Budesonide for Rhinosinusitis. Completed, enrolled 19 participants across 3 sites.
Detailed Summary
The study should create data for the selection of a clinically relevant endpoint to assess the potential of Buparid/PARI SINUS to postpone sinus surgery in patients with chronic Rhinosinusitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinosinusitis
CountriesGermany
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartOct 2015
Primary CompletionSep 2018
Study CompletionJul 2021
TodayJul 2026
First PostedOct 8, 2013
Enrollment StartOct 27, 2015
Primary CompletionSep 27, 2018
Study CompletionJul 29, 2021
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.7 years ago
Interventions
Budesonidedrug
Inhalation
Budesonidedrug
Nasal Spray